Skip to content
PIL Logo

Nebido 1000mg/4ml, solution for injection

Last Updated on eMC 25-Sep-2017 View document  | Bayer plc Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 25-Sep-2017 and displayed until Current

Reasons for adding or updating:

  • Change to section 6 - date of revision
  • Change to section 6 - marketing authorisation holder

Updated on 24-Jul-2017 and displayed until 25-Sep-2017

Reasons for adding or updating:

  • Change to section 6 - date of revision
  • Change to section 6 - manufacturer

Updated on 18-Jan-2017 and displayed until 24-Jul-2017

Reasons for adding or updating:

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 6 - date of revision

Updated on 13-Jul-2016 and displayed until 18-Jan-2017

Reasons for adding or updating:

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 6 - date of revision

Updated on 15-Feb-2016 and displayed until 13-Jul-2016

Reasons for adding or updating:

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 6 - date of revision

Updated on 10-Dec-2014 and displayed until 15-Feb-2016

Reasons for adding or updating:

  • Change to section 6 - date of revision
  • Improved presentation of PIL

Updated on 05-Dec-2012 and displayed until 10-Dec-2014

Reasons for adding or updating:

  • Change to section 3 - how to take/use
  • Change to section 6 - date of revision

Updated on 08-Oct-2012 and displayed until 05-Dec-2012

Reasons for adding or updating:

  • Updates to formatting

Updated on 07-Oct-2011 and displayed until 08-Oct-2012

Reasons for adding or updating:

  • Change to date of revision
  • Change to name of manufacturer

Updated on 30-Aug-2011 and displayed until 07-Oct-2011

Reasons for adding or updating:

  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects

Updated on 22-Feb-2011 and displayed until 30-Aug-2011

Reasons for adding or updating:

  • Change to Further Information section
  • Change to side-effects

Updated on 14-May-2009 and displayed until 22-Feb-2011

Reasons for adding or updating:

  • Change due to harmonisation of PIL.

Updated on 08-Jul-2008 and displayed until 14-May-2009

Reasons for adding or updating:

  • Change to Marketing Authorisation Holder

Updated on 29-Aug-2007 and displayed until 08-Jul-2008

Reasons for adding or updating:

  • Change of manufacturer

Updated on 12-Jan-2005 and displayed until 29-Aug-2007

Reasons for adding or updating:

  • New PIL for new product

Company contact details

Company image
Address

400 South Oak Way, Reading, Berkshire, RG2 6AD

Telephone

+44 (0)118 206 3000

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

testosterone undecanoate

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue